+44 (0)1983 534373 Research: email@example.com | NHS Clinical Allergy: firstname.lastname@example.org
Altoderm is a new topical formulation of sodium cromoglycate developed by Thornton & Ross Ltd. The David Hide Asthma and Allergy Research Centre participated in the clinical testing of this new agent.
Children with moderate to severe atopic dermatitis were enrolled in a randomised double-blind, placebo-controlled study of Altoderm.
The study is now complete and the results, showing a clinically useful benefit of the sodium cromoglycate lotion in children with moderately severe atopic dermatitis, were published in the British Journal of Dermatology.